Great Lakes Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

Great Lakes Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$45.35 - $57.91 $7.31 Million - $9.33 Million	-161,130 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$52.6 - $63.29 $8.48 Million - $10.2 Million	161,130 New	161,130 $8.48 Million
Q4 2017 Feb 08, 2018	SELL	$29.7 - $45.7 $537,094 - $826,438	-18,084 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$25.1 - $31.05 $453,908 - $561,508	18,084	18,084 $562,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.